Table I.
Distribution of patients and treatment episodes for patients in cohort 2
| Treatment | Treatment episodes, n |
|
|---|---|---|
| Patientsa | Treatment episodes | |
| Systemic treatment | ||
| Alitretinoin | 218 | 285 |
| Azathioprine | 783 | 1,187 |
| Cyclosporine | 961 | 2,120 |
| Dupilumab | 607 | 696 |
| Methotrexate | 2,608 | 3,621 |
| Mycophenolate mofetil | 184 | 907 |
| Topical agents for dermatitis | ||
| Dispensed emollients | 3,891 | 9,877 |
| Crisaborole | – | – |
| Pimecrolimus | 713 | 919 |
| Tacrolimus | 2,387 | 4,705 |
| Topical corticosteroids | 4,002 | 12,180 |
a
Patients may have had a systemic treatment episode with >1 systemic treatment with patient numbers reflecting each occurrence.